CMMB - Company ID 0001534248
Chemomab Therapeutics Ltd. trades as CMMB. This page tracks Chemomab Therapeutics Ltd. through 345 SEC filings, with financial statements and metrics updated as new reports are filed.
Research snapshot
Updated
With latest filings
Next research step
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.
| Filing | Type | Filed |
|---|---|---|
| 6-K | - | 2026-05-14 |
| 6-K | - | 2026-05-06 |
| 6-K | - | 2026-04-28 |
| New insider ownership | 3 | 2026-04-10 |
| New insider ownership | 3 | 2026-04-10 |
| New insider ownership | 3 | 2026-04-10 |
| New insider ownership | 3 | 2026-04-10 |
| New insider ownership | 3 | 2026-04-10 |
The largest companies sharing Chemomab Therapeutics Ltd.'s SEC industry classification (pharmaceutical preparations).
In its latest fiscal year Chemomab Therapeutics Ltd. reported a net loss of $8.99M.